10 Year Financial Data of Boston Scientific, Inc. (BSX)

9.4 (1y: +64%)

Market Cap	12.87 B	P/E(ttm)
Enterprise Value	16.86 B	P/B	1.90

BSX- NYSE (USA)
Boston Scientific, Inc.

Currently 1/5

Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$9.40

2 Severe Warning Signs 2 Medium Warning Signs

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	-1.3	-1.6	2.2
EBITDA Growth (%)	0	0	-362.6
Free Cash Flow Growth (%)	-15.6	8.3	6
Book Value Growth (%)	4.4	4.4	-38.6

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	4.12	6.57	7.50	6.14	5.62	5.37	5.43	5.14	5.02	5.15	5.16	1.28	1.28	1.25	1.33	1.30
EBITDA per Share	1.06	2.16	1.53	-1.70	0.62	-0.43	-0.04	0.11	1.07	-2.26	-2.60	0.13	-2.52	-0.43	0.59	-0.24
Free Cashflow per Share	0.71	1.79	0.67	1.18	0.38	0.57	0.35	0.03	0.46	0.74	0.71	0.10	0.25	0.16	0.22	0.08
Earnings per Share ($)	0.56	1.24	0.75	-2.81	-0.33	-1.36	-0.68	-0.70	0.29	-2.89	-3.21	0.08	-2.51	-0.48	0.05	-0.26
Book Value per Share	3.40	4.70	5.11	12.02	10.15	8.79	8.16	7.44	7.47	4.88	4.81	7.84	5.43	4.90	5.03	4.81
Month End Stock Price	36.76	35.55	24.49	17.18	11.63	7.74	9.00	7.57	5.34	5.73	7.81	5.98	5.67	5.74	5.73	7.81
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	16.50	26.40	14.70	-23.40	-3.30	-15.50	-8.30	-9.40	3.90	-59.20	-21.60	4.00	-185	-38.80	3.60	-21.60
Return on Assets %	8.30	13.00	7.70	-11.50	-1.60	-7.50	-4.10	-4.80	2.10	-23.70	-8.40	2.00	-80.40	-15.60	1.60	-8.40
Return on Capital - Joel Greenblatt %	62.60	138	65.80	-126	-0.40	-65.20	-46.90	-21.90	33.40	-148	-48.00	28.00	-556	-90.40	18.00	-48.00
Debt to Equity	0.60	0.59	0.47	0.58	0.54	0.51	0.48	0.48	0.38	0.62	0.65	0.37	0.55	0.62	0.62	0.65

Gross Margin %	72.40	77.00	77.90	71.80	72.00	69.30	68.50	66.70	65.10	67.60	67.20	66.20	68.40	67.80	68.00	67.20
Operating Margin %	20.10	28.00	15.40	-37.70	-0.20	-18.70	-10.90	-8.40	11.90	-53.40	-18.70	10.50	-196	-34.20	6.40	-18.70
Net Margin %	13.60	18.90	10.00	-45.70	-5.90	-25.30	-12.50	-13.60	5.80	-56.10	-20.10	6.10	-196	-38.30	3.30	-20.10

Days Sales Outstanding	56.90	58.40	54.10	66.50	65.60	63.60	61.30	61.70	59.70	61.30	63.70	64.20	61.90	62.80	60.80	63.70
Days Inventory	107	102	110	124	113	126	130	126	128	137	134	128	141	149	138	134
Inventory Turnover	3.40	3.60	3.30	2.90	3.20	2.90	2.80	2.90	2.90	2.70	0.70	0.70	0.60	0.60	0.70	0.70

Debt to Revenue	0.50	0.42	0.32	1.14	0.98	0.84	0.72	0.70	0.56	0.59	2.42	2.28	2.33	2.45	2.34	2.42
COGS to Revenue	0.28	0.23	0.22	0.28	0.28	0.31	0.31	0.33	0.35	0.32	0.33	0.34	0.32	0.32	0.32	0.33
Inventory to Revenue	0.08	0.06	0.07	0.10	0.09	0.11	0.11	0.12	0.12	0.12	0.48	0.48	0.49	0.53	0.49	0.48
Interest Exp. to Revenue %	-1.32	-1.14	-1.43	-4.71	-6.82	-5.81	-4.97	-5.04	-3.69	-3.60	-3.58	-3.70	-3.50	-3.75	-3.52	-3.58

Asset Turnover	0.61	0.69	0.77	0.25	0.27	0.30	0.33	0.35	0.36	0.42	0.11	0.09	0.10	0.10	0.11	0.11
Buyback Ratio	-55.10	-21.20	-15.00	43.20	26.70	3.50	3.20	2.90	--	0.50	--	--	--	--	--	--
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	3,476	5,624	6,283	7,821	8,357	8,050	8,188	7,806	7,622	7,249	7,145	1,866	1,828	1,735	1,821	1,761
Cost of Goods Sold	961	1,292	1,386	2,207	2,342	2,469	2,576	2,599	2,659	2,349	2,296	631	578	558	582	578
Gross Profit	2,515	4,332	4,897	5,614	6,015	5,581	5,612	5,207	4,963	4,900	4,849	1,235	1,250	1,177	1,239	1,183

Selling, General, &Admin. Expense	1,171	1,742	1,814	2,675	2,909	2,792	4,848	2,765	2,659	2,688	2,654	707	696	618	668	672
Research &Development	452	569	680	1,008	1,091	1,006	1,035	939	895	886	875	215	213	220	238	204
Earnings Before DDA	893	1,849	1,282	-2,168	925	-641	-60.00	160	1,621	-3,185	-3,711	196	-3,587	-594	800	-330

Depreciation, Depletion and Amortization	196	275	314	781	939	864	834	816	717	683	683	--	--	--	683	--

Operating Income	697	1,574	968	-2,949	-14.00	-1,505	-894	-656	904	-3,868	-4,394	196	-3,587	-594	117	-330
Interest Income/Expense	-46.00	-64.00	-90.00	-368	-570	-468	-407	-393	-281	-261	-256	-69.00	-64.00	-65.00	-64.00	-63.00
Net Income	472	1,062	628	-3,577	-495	-2,036	-1,025	-1,065	441	-4,068	-4,535	113	-3,578	-664	61.00	-354

Earnings per Share ($)	0.56	1.24	0.75	-2.81	-0.33	-1.36	-0.68	-0.70	0.29	-2.89	-3.21	0.08	-2.51	-0.48	0.05	-0.26
Total Shares Outstanding	843	856	837	1,273	1,487	1,499	1,508	1,518	1,519	1,407	1,352	1,454	1,423	1,393	1,366	1,352
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	671	1,640	848	1,668	1,452	1,641	864	213	267	207	268	284	371	352	207	268
Accounts Receivable	542	900	932	1,424	1,502	1,402	1,375	1,320	1,246	1,217	1,232	1,316	1,243	1,197	1,217	1,232
Inventory	281	360	418	749	725	853	920	894	931	884	851	889	898	911	884	851
Other Current Assets	386	389	433	1,060	2,242	1,556	902	1,188	661	714	751	602	599	713	714	751
Total Current Assets	1,880	3,289	2,631	4,901	5,921	5,452	4,061	3,615	3,105	3,022	3,102	3,091	3,111	3,173	3,022	3,102

Property, Plant and Equipment	744	870	1,011	1,726	1,735	1,728	1,728	1,697	1,670	1,564	1,537	1,669	1,632	1,624	1,564	1,537
Intangible Assets	2,461	3,340	3,735	23,636	23,067	19,665	19,135	16,529	16,234	12,262	11,729	16,144	12,723	11,878	12,262	11,729
Other Long Term Assets	614	671	819	833	474	294	253	287	281	306	395	281	352	223	306	395
Total Assets	5,699	8,170	8,196	31,096	31,197	27,139	25,177	22,128	21,290	17,154	16,763	21,185	17,818	16,898	17,154	16,763

Accounts Payable	675	1,010	1,229	2,067	2,680	3,012	2,821	1,810	1,530	1,516	1,392	1,468	1,588	1,553	1,516	1,392
Current Portion of Long-Term Debt	553	1,228	156	7.00	256	2.00	3.00	504	4.00	4.00	4.00	4.00	4.00	3.00	4.00	4.00
Other Current Liabilities	165	367	94.00	556	314	219	198	295	273	252	240	197	202	259	252	240
Total Current Liabilities	1,393	2,605	1,479	2,630	3,250	3,233	3,022	2,609	1,807	1,772	1,636	1,669	1,794	1,815	1,772	1,636

Long-Term Debt	1,172	1,139	1,864	8,895	7,933	6,743	5,915	4,934	4,257	4,252	4,250	4,255	4,253	4,252	4,252	4,250
Other Long-Term Liabilities	272	401	571	4,273	4,917	3,989	3,939	3,289	3,873	4,260	4,374	3,865	4,043	4,003	4,260	4,374
Total Liabilities	2,837	4,145	3,914	15,798	16,100	13,965	12,876	10,832	9,937	10,284	10,260	9,789	10,090	10,070	10,284	10,260

Common Stock	8.00	8.00	8.00	15.00	15.00	15.00	15.00	15.00	15.00	15.00	16.00	15.00	15.00	15.00	15.00	16.00
Retained Earnings	1,789	2,790	3,410	-174	-693	-2,732	-3,757	-4,822	-4,381	-8,449	-8,803	-4,268	-7,846	-8,510	-8,449	-8,803
Additional Paid-In Capital	1,225	1,633	1,658	15,792	15,788	15,944	16,086	16,232	16,349	16,429	16,437	16,358	16,388	16,427	16,429	16,437
Treasury Stock	-111	-320	-717	-334	--	--	--	--	-492	-1,092	-1,192	-630	-742	-992	-1,092	-1,192
Total Equity	2,862	4,025	4,282	15,298	15,097	13,174	12,301	11,296	11,353	6,870	6,503	11,396	7,728	6,828	6,870	6,503
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	472	1,062	628	-3,577	-495	-2,036	-1,025	-1,065	--	-4,068	-4,068	--	--	--	-4,068	--
Depreciation, Depletion and Amortization	196	275	314	781	939	864	834	816	717	683	683	--	--	--	683	--
Cash Flow from Others	119	467	-39.00	4,641	490	2,388	1,026	574	291	4,645	4,596	212	407	272	3,754	163
Cash Flow from Operations	787	1,804	903	1,845	934	1,216	835	325	1,008	1,260	1,211	212	407	272	369	163

Investment for Property, Plant & Equipement	-188	-274	-341	-341	-363	-362	-312	-278	-304	-226	-213	-66.00	-52.00	-46.00	-62.00	-53.00
Cash Flow from Acquisitions	-13.00	-804	-211	-9,083	-261	535	-527	-211	1,063	-378	-382	-3.00	-136	-3.00	-236	-7.00
Cash Flow from Investing	-871	-1,622	-551	-9,312	-474	324	-793	-480	769	-579	-521	-69.00	-188	-49.00	-273	-11.00

Net Issuance of Stock	-310	-135	-640	1,545	72.00	71.00	33.00	31.00	-471	-579	-540	-129	-112	-239	-99.00	-90.00
Net Issuance of Debt	793	577	-313	6,888	-754	-1,425	-853	-527	-1,250	-19.00	-19.00	--	-18.00	--	-1.00	--
Other Financing	4.00	-3.00	-1.00	6.00	2.00	4.00	--	--	--	-146	-146	--	--	-4.00	-142	--
Cash Flow from Financing	487	439	-954	8,439	-680	-1,350	-820	-496	-1,721	-744	-705	-129	-130	-243	-242	-90.00

Net Change in Cash	411	625	-607	979	-216	189	-777	-651	54.00	-60.00	-16.00	17.00	87.00	-19.00	-145	61.00

Free Cash Flow	599	1,530	562	1,504	571	854	523	47.00	704	1,034	998	146	355	226	307	110
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

BSX Quarterly/Annuals Reports

BSX: 10-Q - BOSTON SCIENTIFIC CORP (0000885725) (Filer): (10-Q) - 2012-11-06
BSX: 10-Q - BOSTON SCIENTIFIC CORP (0000885725) (Filer): (10-Q) - 2012-08-07
BSX: 10-Q - BOSTON SCIENTIFIC CORP (0000885725) (Filer): (10-Q) - 2012-05-03
BSX: 10-K - BOSTON SCIENTIFIC CORP (0000885725) (Filer): (10-K) - 2012-02-17
BSX: 10-Q - BOSTON SCIENTIFIC CORP (0000885725) (Filer): (10-Q) - 2011-11-08

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

BSX Quarterly/Annuals Reports